Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review.

ABSTRACT:

Background

Surgical resection remains the only curative treatment for pancreatic cancer and is associated with significant post-operative morbidity and mortality. Patients eligible for surgery, increasingly receive neo-adjuvant therapy before surgery or adjuvant therapy afterward, inherently exposing them to toxicity. As such, optimizing physical function through exercise during treatment remains imperative to optimize quality of life either before surgery or during rehabilitation. However, current exercise efficacy and prescription in pancreatic cancer is unknown. Therefore, this study aims to summarise the published literature on exercise studies conducted in patients with pancreatic cancer undergoing treatment with a focus on determining the current prescription and progression

SUBMITTER: O'Connor D 

PROVIDER: S-EPMC7794639 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature